Viracta Therapeutics (VIRX) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Viracta Therapeutics Revenue Highlights


00

Viracta Therapeutics Revenue by Period


Viracta Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31$120.00K-94.21%
2019-12-31$2.07M774.68%
2018-12-31$237.00K-64.57%
2017-12-31$669.00K-73.62%
2016-12-31$2.54M-17.15%
2015-12-31$3.06M-46.62%
2014-12-31$5.73M-27.93%
2013-12-31$7.96M111.93%
2012-12-31$3.75M-24.92%
2011-12-31$5.00M15013.50%
2010-12-31$33.08K-99.12%
2009-12-31$3.76M-30.56%
2008-12-31$5.42M-43.94%
2007-12-31$9.66M-29.51%
2006-12-31$13.71M-17.02%
2005-12-31$16.52M-

Viracta Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Viracta Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$738.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31$120.00K-94.21%
2019-12-31$2.07M100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30--100.00%
2018-03-31$237.00K100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30--100.00%
2017-03-31$669.00K-1.04%
2016-12-31$676.00K10.82%
2016-09-30$610.00K-
2016-06-30$610.00K-4.69%
2016-03-31$640.00K-4.48%
2015-12-31$670.00K-1.90%
2015-09-30$683.00K-20.02%
2015-06-30$854.00K-
2015-03-31$854.00K-4.69%
2014-12-31$896.00K4.92%
2014-09-30$854.00K-57.06%
2014-06-30$1.99M-0.30%
2014-03-31$2.00M0.30%
2013-12-31$1.99M-
2013-09-30$1.99M-
2013-06-30$1.99M-
2013-03-31$1.99M-
2012-12-31$1.99M650.57%
2012-09-30$265.00K-82.33%
2012-06-30$1.50M100.00%
2012-03-31-100.00%
2011-12-31--100.00%
2011-09-30$1.00M100.00%
2011-06-30--100.00%
2011-03-31$4.00M66566.67%
2010-12-31$6.00K100.00%
2010-09-30--100.00%
2010-06-30$14.58K16.66%
2010-03-31$12.50K-
2009-12-31$12.50K-
2009-09-30$12.50K-99.64%
2009-06-30$3.51M1467.75%
2009-03-31$224.05K1692.38%
2008-12-31$12.50K-97.55%
2008-09-30$510.42K-80.30%
2008-06-30$2.59M12.51%
2008-03-31$2.30M12.53%
2007-12-31$2.05M11.83%
2007-09-30$1.83M-

Viracta Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Viracta Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
EYPTEyePoint Pharmaceuticals$46.02M$9.48M
BCYCBicycle Therapeutics$26.98M$2.68M
SQZSQZ Bio$21.03M-
MREOMereo BioPharma Group$10.00M-
STOKStoke Therapeutics$8.78M$4.22M
IGMSIGM Biosciences$2.13M$497.00K
LYRALyra Therapeutics$1.56M$598.00K
ALXOALX Oncology--
XFORX4 Pharmaceuticals-$563.00K
CABACabaletta Bio--
RLYBRallybio-$299.00K
TARAProtara Therapeutics--
INZYInozyme Pharma--
LPTXLeap Therapeutics--
VIRXViracta Therapeutics--
BMEABiomea Fusion--
TRVITrevi Therapeutics--
TERNTerns Pharmaceuticals--
VINCVincerx Pharma--
GLUEMonte Rosa Therapeutics-$4.70M
TNYATenaya Therapeutics--

VIRX Revenue FAQ


Viracta Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. VIRX's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.

Viracta Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). VIRX's quarterly revenue for Q4 2023 was $738K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

Viracta Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.